deferiprone has been researched along with Hematoma in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, G | 1 |
| Hu, W | 1 |
| Tang, Q | 1 |
| Wang, L | 1 |
| Sun, XG | 1 |
| Chen, Y | 1 |
| Yin, Y | 1 |
| Xue, F | 1 |
| Sun, Z | 1 |
1 other study available for deferiprone and Hematoma
| Article | Year |
|---|---|
Effect Comparison of Both Iron Chelators on Outcomes, Iron Deposit, and Iron Transporters After Intracerebral Hemorrhage in Rats.
Topics: Animals; Brain; Brain Edema; Cation Transport Proteins; Cerebral Hemorrhage; Clioquinol; Deferiprone | 2016 |